Tag: alphaproteo

Google DeepMind has unveiled an AI system called AlphaProteo that can design novel proteins that successfully bind to target molecules, potentially revolutionising drug design and disease research. AlphaProteo can generate new protein binders for diverse target proteins, including VEGF-A, which is associated with cancer and diabetes complications. Notably, this is the first time an AI…